"This study shows that it’s feasible to evaluate both response and progression using a simple, relatively inexpensive blood test. It can give the physician and the patient confidence that the therapy ...

In the article that accompanies this editorial, Luminari et al 6 describe results of a randomized study evaluating a response-adapted approach in the frontline treatment of follicular lymphoma (FL).

Characteristics and Survival Outcomes of Patients With Metastatic RET Fusion–Positive Solid Tumors Receiving Non-RET Inhibitor Standards of Care in a Real-World Setting We evaluated the clinical ...

A research team has discovered a highly potent biomarker for clinical response to CAR-T cell therapy, describing the prerequisites for optimal use of this novel therapy for lymphoma treatment. The ...

Therapist-supported internet-based exposure and response therapy led to higher response rates and was cost effective for young persons with Tourette syndrome or chronic tic disorder compared with ...